Late-Life Presentation of Unsuspected G6PD Deficiency - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Sep 25:2018:8198565.
doi: 10.1155/2018/8198565. eCollection 2018.

Late-Life Presentation of Unsuspected G6PD Deficiency

Marcos Benchimol  1 , Laura Bernardo Madeira  1 , Ricardo de Oliveira-Souza  2   3
Affiliations
Case Reports

Late-Life Presentation of Unsuspected G6PD Deficiency

Marcos Benchimol et al. Case Rep Crit Care. .

Abstract

Deficiency of glucose-6-phosphate dehydrogenase (G6PD) is the commonest enzyme deficiency in humans with a wide range of possible clinical manifestations depending on the specific genetic variant in each case. Here we present the case of an 86-year-old male of African descent who acutely developed symptoms of G6PD deficiency immediately after he received methylene blue for treating methemoglobinemia. The contrast between a low SO2 on pulse oximetry and a normal arterial gas sampling raised the possibility of methemoglobinemia. The patient was treated with packed red blood cells and folic acid, and a rapid clinical improvement followed by normalization of the red blood cell count ensued. In view of the patient's advanced age, the lack of a history of similar episodes in the past, and the normal laboratory results during the hemolytic crisis, this case remained a diagnostic challenge for over three months, when a follow-up measure of G6DP activity eventually confirmed the diagnosis. A latent deficiency of G6PD may become clinically manifest under the appropriate triggering conditions even in elderly patients and in the absence of past or current clinical and laboratory evidence of G6PD deficiency.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Peripheral blood smear showing polychromatophilia, numerous microspherocytes, and erythroblasts, some of which are dysplastic; schizocytes, Heinz bodies, and “bite cells” were not seen (Giemsa stain).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

  • Favism: A Case Report.
    Diegues A, Simões P, Ceriz T, Lopes AR, Tomé E. Diegues A, et al. Cureus. 2022 Mar 17;14(3):e23269. doi: 10.7759/cureus.23269. eCollection 2022 Mar. Cureus. 2022. PMID: 35449616 Free PMC article.

References

    1. Yoshida A., Stamatoyannopoulos G., Motulsky A. G. Negro variant of glucose-6-phosphate dehydrogenase deficiency (A-) in man. Science. 1967;155(3758):97–99. doi: 10.1126/science.155.3758.97. - DOI - PubMed
    1. Cappellini M., Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. The Lancet. 2008;371(9606):64–74. doi: 10.1016/S0140-6736(08)60073-2. - DOI - PubMed
    1. Beutler E. Glucose-6-phosphate dehydrogenase deficiency: a historical perspective. Blood. 2008;111(1):16–24. doi: 10.1182/blood-2007-04-077412. - DOI - PubMed
    1. Beutler E. The molecular biology of enzymes of erythrocyte metabolism. In: Stamatoyannopoulos G., Nienhuis A. W., Leder P., Majerus P. W., editors. The Molecular Basis of Blood Disease. Vol. 29. Philadelphia, USA: WB Saunders; 1993. - DOI
    1. Balwani M. R., Bawankule C. P., Ramteke V., Tolani P., Vakil S., Yadav R. Methylene blue induced methemoglobinemia with acute kidney injury in a glucose-6-phosphate dehydrogenase-deficient patient. Indian Journal of Nephrology. 2017;27(6):465–467. doi: 10.4103/ijn.IJN_316_16. - DOI - PMC - PubMed

Publication types

LinkOut - more resources